Count | |
8 | |
8 | |
6 | |
37 | |
4 | |
3 | |
2 | |
1 | |
1 | |
62 | |
7 | |
1 | |
25 | |
30 | |
1 | |
1 | |
2 | |
1 | |
1 | |
2 | |
1 | |
7 | |
20 | |
1 | |
1 | |
1 | |
2 | |
1 | |
2 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
Blood Component Transfusion/adverse effects/*methods/standards | 1 |
1 | |
3 | |
1 | |
1 | |
Platelet Aggregation Inhibitors/*adverse effects/pharmacology | 1 |
Platelet Aggregation Inhibitors/adverse effects/*therapeutic use | 1 |
Platelet Aggregation Inhibitors/*adverse effects/therapeutic use | 1 |
Platelet Aggregation Inhibitors/adverse effects/therapeutic use | 1 |
Transfusion-Transmitted Virus/*drug effects/growth & development | 1 |
1 | |
131 | |
59 | |
215 | |
36 | |
33 | |
1 | |
9 | |
1 | |
7 | |
44 | |
14 | |
31 | |
64 | |
1 | |
1 | |
4 | |
4 | |
1 | |
1 | |
3 | |
2 | |
17 | |
8 | |
8 | |
1 | |
1 | |
1 | |
2 | |
1 | |
2 | |
1 | |
3 | |
20 | |
5 | |
17 | |
4 | |
10 | |
3 | |
2 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
Platelet Membrane Glycoproteins/*drug effects/metabolism/secretion | 1 |